Trends and Variations in General Medical Services Indicators For Hypertension: Analysis of QRESEARCH Data

Similar documents
Trends and Variations in General Medical Services Indicators for Coronary Heart Disease: Analysis of QRESEARCH Data

An Analysis of Prescribing of Methylphenidate Hydrochloride in QRESEARCH

Repeat Prescribing in Elderly People: an Analysis of QRESEARCH Data

Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework

Obesity in the United Kingdom: Analysis of QRESEARCH data

Polypharmacy in the Elderly: Analysis of QRESEARCH Data

QRESEARCH ADVISORY BOARD MEETING. University of Nottingham London Office, Berners Street, London W1T 3NB. Thursday 22 June 2006 Minutes

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

East London Community Kidney Service

Validation of QFracture. Analysis prepared for NICE 2011

Trends in the epidemiology of smoking recorded in UK general practice Colin R Simpson, Julia Hippisley-Cox and Aziz Sheikh

REPORT TO THE DISABILITY RIGHTS COMMISSION

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2006

Has the UK had a double epidemic?

Breast Test Wales Screening Division Public Health Wales

QStatin Update Information

Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study

South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member

RESEARCH. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores

2. Quality and Outcomes Framework: new NICE recommendations

Primary Care Commission Study Visit. 26 March 2015

RESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore

New GMS Contract QOF Implementation Dataset And Business Rules - Depression Indicator Set

The Nottingham eprints service makes this work by researchers of the University of Nottingham available open access under the following conditions.

Campaigns Overview. Lisa Bainbridge Head of Campaigns 14 October 2017

Population risk stratification in outcome analysis - approaches and innovative solutions

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities

Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey

Quit Rates of New York State Smokers

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

RESEARCH. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Kansas EMS Naloxone (Narcan) Administration

RESEARCH. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

How a universal health system reduces inequalities: lessons from England

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

FORECASTING THE DEMAND OF INFLUENZA VACCINES AND SOLVING TRANSPORTATION PROBLEM USING LINEAR PROGRAMMING

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

HPV Immunisation Uptake Statistics for the Catch-up Programme

NHS QIS National Measurement of Audit Acute Coronary Syndrome

Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case control analysis

Validation of QRISK2 (2014) in patients with diabetes

Electronic Prescription Service in England. Ian Lowry Programme Manager

PERFORMANCE AGAINST IMMUNISATION TIER 1 TARGETS

Summary of 2012/13 QOF Changes

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Ethnic group differences in CVD risk estimates using JBS2 and QRISK2 risk scores. Dr Andrew R H Dalton

Wyoming Quit Tobacco Program Follow-Up Survey

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2011

ESPA Directorate KPI Report: Quarter 1,

Population intermediate outcomes of diabetes under pay for performance incentives in England from 2004 to 2008

BSA New Zealand Hawkes Bay District Health Board Coverage Report

Optimising Hypertension Management Clair Huckerby Pharmaceutical Adviser- Medicines Optimisation Lead

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

Identifying patients with undetected pancreatic cancer in primary care:

Dementia Content Report May Produced By The NHS Choices Reporting Team

The General Practice Research Database (GPRD) Further Information for Patients

Physical Health Checks

Coronary heart disease prevention and age inequalities:

Monitoring hepatitis C treatment uptake in Australia

INFORMATION TO SUPPORT THE DEVELOPMENT OF THE LINCOLNSHIRE CANCER STRATEGY

Practical advice on smoking cessation: Patients with long-term conditions

The Single Cancer Pathway

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

Colorado State Innovation Model (SIM) Clinical Quality Measures (CQMs) Reporting Schedules

The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Texas Vendor Drug Program Specialty Drug List Process. February 2019

HIV Care & Treatment Program STATE OF OREGON

Developing a QAPI Program for Cardiovascular Health Improvement

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd

South Wales Street Based Lifestyle Monitor

Cardiovascular disease profile

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

Touchpoints Prior to Opioid Overdose Death

HIV Care & Treatment STATE OF OREGON

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

Commissioning for Better Outcomes in COPD

NHS Dental Statistics for England: 2009/10

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

RESEARCH. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

Executive Summary. Classes Under Review: Analysis:

International experience. Local knowledge.

Inequalities in uptake of influenza vaccine by deprivation and risk group: Time trends analysis

Sleep Market Panel. Results for June 2015

Statistics on Smoking Cessation Services in Northern Ireland: 2008/2009

Keeping older people safe in our care

McLean ebasis plus TM

GP Insight Report. The Family Practice CQC ID:

Arkansas Prescription Monitoring Program

National Lung Cancer Audit outlier policy 2017

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18

IHN-CCO DST Final Report and Evaluation

Dementia Content Report January Produced By The NHS Choices Reporting Team

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Transcription:

Trends and Variations in General Medical Services Indicators For Hypertension: Analysis of QRESEARCH Data Authors: Professor Julia Hippisley-Cox Professor Mike Pringle Gavin Langford Professor of Clinical Epidemiology and General Practice Professor of General Practice Programmer/analyst Institution University of Nottingham Report reference number DH 19 Report version number 1.0 Final submission date March 2005 QRESEARCH Database version QRESEARCH version 5 Funding body Department of Health Web link http://www.qresearch.org Acknowledgments QRESEARCH is a not-for-profit partnership between the University of Nottingham and EMIS. We acknowledge the contribution of EMIS and to the practices which contribute data Copyright QRESEARCH 2007, all rights reserved Terms of usage These reports can be used for personal education, research, health service planning and private study. Materials should not be further copied, photocopied or reproduced, or distributed in electronic form. Any material which is referenced should refer to QRESEARCH and the database version. Any use or distribution for commercial purposes is expressly forbidden and may constitute an infringement of the University's copyright and may lead to legal action. Page 1 of 31

1 EXECUTIVE SUMMARY This report has three main objectives: 1. To determine the inter-practice variation in achievement of 5 indicators for hypertension care using the ngms measures on the 30th September 2004 2. To describe trends in achievement of each indicator every quarter for the last 3 years (1 st October 2001-30 st Sep 2004) 3. To report on the pattern of usage of the newly introduced exception codes The key findings are: All practices could meet the requirement for a disease register for hypertension (Indicator 1). The prevalence of hypertension has risen from 97 per 1000 registered patients in the first quarter (October - December 2001) to 115 per 1000 by the last quarter examined (July September 2004). There is substantial inter-practice variation in prevalence of hypertension with a normal distribution. The percentage of patients with hypertension and smoking status recorded (Indicator 2) varies markedly between practices with a long tail at the lower end. The trend in recording smoking status is upwards with over 90% having smoking status recorded by the last quarter of 2004. The recording of smoking cessation advice (Indicator 3) exceeded 90% in the last quarter. By the final quarter in 2004 a steady trend had yielded a rise from 80% to 88% overall in the proportion of people with hypertension who have a recorded blood pressure reading in the previous 9 months (Indicator 4). In terms of hypertensive control (BP of 150/90 or less Indicator 5) there has been a rise from 46% to 67% over the 3 years, with a steeper rise in recent quarters. In recent quarters there has been some use of the hypertension resolved codes but it is still minimal. Page 2 of 31

Hypertension exception codes which are used 10 times more frequently than hypertension resolved codes, and with use increasing in recent quarters. Maximum therapy exclusion codes were used at a similar level to the hypertension exception codes. Blood pressure recording exception codes were only present in 4 patients. Page 3 of 31

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY...2 2 TABLE OF FIGURES...5 3 OBJECTIVES...6 4 METHOD...6 4.1 Version of database used...6 4.2 Study period...6 4.3 Practice inclusion criteria...6 4.4 Patient inclusion criteria...6 4.5 Case definition for hypertension...6 4.6 Definition of the quality indicators...7 4.7 General exclusions...7 5 RESULTS...7 5.1 Study population...7 5.2 Patients with Hypertension resolved...8 5.3 Patients with Hypertension exception code...9 5.4 Hypertension indicator 1: % with a register...10 5.5 Hypertension Indicator 1: Quarterly Trends...11 5.6 Hypertension Indicator 2: % with smoking status recorded...12 5.7 Hypertension Indicator 2: Quarterly Trends...13 5.8 Hypertension Indicator 3: % of smokers receiving smoking cessation advice...14 5.9 Hypertension indicator 3: Quarterly Trends...15 5.10 Hypertension Indicator 4: % with a blood pressure recorded...16 5.11 Hypertension Indicator 4: Exclusions...17 5.12 Hypertension indicator 4: Quarterly Trends...17 5.13 Hypertension Indicator 5: % with a BP of 150 and 90 mm Hg or less...18 5.14 Hypertension Indicator 5: Exclusions...19 5.15 Hypertension Indicator 5: Quarterly Trends...20 6 DISCUSSION...21 7 FUTURE WORK...22 8 REFERENCES...22 9 APPENDIX...23 Page 4 of 31

2 TABLE OF FIGURES Table 1: Trends in median practice prevalence rate of hypertension per 1000 registered patients...23 Table 2: Trends in practice median percentage with hypertension resolved code...24 Table 3: Trends in median practice percentage with hypertension exception code...25 Table 4 Practice median % of hypertension patients with smoking history recorded since diagnosis...26 Table 5 Practice median % of hypertension patients who smoke...27 Table 6 Practice median % of hypertension patients who smoke who have had smoking advice given ever28 Table 7: Practice median percentage of patients with hypertension with a code for maximal antihypertensive therapy code...29 Table 8 Practice median % of hypertension patients who have had BP check in the last 9 months...30 Table 9 Practice median % of hypertension patients who have BP <=159/90 mmhg...31 Page 5 of 31

3 OBJECTIVES This report has three main objectives: To determine the inter-practice variation in achievement of 5 indicators for hypertension care using the ngms measures in the last quarter of 2004 (July 2004 to September 2004) To describe quarterly trends in achievement of each indicator for the last 3 years (October 2001 to September 2004). To report on the pattern of usage of the newly introduced exception codes 4 METHOD 4.1 Version of database used The 5 th national version of the QRESEARCH database was used for this analysis. This database contains data until 30th September 2004. 4.2 Study period The study period ran from 1 st October 2001 to 30th September 2004 (12 quarters in total). 4.3 Practice inclusion criteria To be included in the analyses, practice had to have EMIS installed before the first day of each study period and have complete data for the each quarter. 4.4 Patient inclusion criteria In order to be included in the analysis, patients had to be registered with the practice on the first day of the relevant quarter. 4.5 Case definition for hypertension Prevalent cases of hypertension were defined by the presence of a Read code for hypertension (G2; G20%; G24-G2z) in their record prior to the end of the analysis period. This is the definition used in the ngms contract. Page 6 of 31

4.6 Definition of the quality indicators We used the New GMS Contract QOF Implementation Dataset and Business Rules Hypertension Indicator set (Version 5.0 release date 27th September 2004). Some of current Read codes [particularly the exception codes ] were not in existence or possibly not used prior to mid 2004. 4.7 General exclusions In general patients are excluded from the denominator for each indicator if they were newly registered with the practice (i.e. registered within the preceding 3 months) or if they were newly diagnosed with hypertension (i.e. diagnosed within the preceding three months) or if they have a Read code including an exception to hypertension reporting code within the previous 15 months. However, if the patients happen to have the required measurement then they could appear in the numerator. There are also some exclusions specific to different indicators. This means that the eligible population for each indicator varies. A summary of the individual exclusions is shown in the appendix. The results for each of the indicators are also discussed in the relevant sections. 5 RESULTS 5.1 Study population There were 469 practices from the QRESEARCH database (5 th version) with complete data for the three year study period which were therefore included in this analysis. There were 3.37 million registered patients on 1 st October 2001 rising to 3.42 million on 30th September 2004. Page 7 of 31

5.2 Patients with Hypertension resolved The next chart shows the variation between practices in the percentage of patients with a hypertension resolved code in the last quarter (July to September 2004). Overall there were just 219 patients with a hypertension resolved code out of 388,000 patients with a diagnosis of hypertension (see Table 2, page 24). This low usage of the code is probably because the code is new. Most uses of this code are likely to be for those misdiagnosed or where the diagnosis was recorded incorrectly. Occasionally, patients modify their lifestyle (e.g. weight reduction) and this can lower blood pressure so it is possible that a few of these were genuine cases where hypertension had resolved. The appendix shows how the use of this code has changed over the 12 quarters (the rates are too low to plot). Most of the increase has occurred in the last 3 quarters. Inter-practice variation in % of hypertensives with hypertension resolved code (July-Sept 04) Number of practices 0 50 100 150 200 250 300 350 0 1 2 3 4 5 6 7 8 9 % of hypertensives with hypertension resolved code Data source: QRESEARCH database, version 5 Page 8 of 31

5.3 Patients with Hypertension exception code There were 2,000 patients with hypertension who had a hypertension exception reporting code recorded in the 12 th quarter. This was 20 times higher than the 106 patients with a hypertension exception code recorded in quarter 9 (October to December 2003). The inter-practice variation in the 12 th quarter is shown in the chart below. Data for all the quarters can be found in the appendix (Table 3, page 25). Inter-practice variation in % of hypertensives with hypertension exception code (July-Sept 04) Number of practices 0 50 100 150 200 250 300 350 400 450 0 1 2 3 4 5 6 % of hypertensives with hypertension exception code Data source: QRESEARCH database, version 5 Page 9 of 31

5.4 Hypertension indicator 1: % with a register Indication BP1: The practice can produce a register of patients with established hypertension. No numerator or denominator is required. Specific exclusions: none all practices are eligible for inclusion in this indicator All practices were able to identify some patients with hypertension and were therefore able to satisfy hypertension indicator one. The next graph shows the inter-practice variation in prevalence of hypertension per 1,000 registered patients in the last quarter of 2004. Tabular data are available in the appendix (Table 1, page 23). The median prevalence was 115 per 1,000 registered patients (inter quartile range 95 to 138). Inter-practice variation in prevalence of hypertension per 1000 patients (Hypertension indicator 1, July-Sept 04) Number of practices 0 10 20 30 40 50 60 70 80 0 50 100 150 200 250 Prevalence of hypertension per 1000 registered patients Data source: QRESEARCH database, version 5 Page 10 of 31

5.5 Hypertension Indicator 1: Quarterly Trends The next chart shows the trends in the median practice prevalence of hypertension per 1000 registered patients for each of 12 quarters between October 2001 to September 2004. Tabular data are available in the appendix (Table 1, page 23). The median practice prevalence rose from 97 per 1,000 registered patients to 115 per 1,000 registered patients over the 12 quarters. Prevalence hypertension per 1000 patients 00 50 100 150 Oct-Dec 01 97.0 99.1 101.4 102.7 105.8 Jan-Mar02 Trends in median practice prevalence of hypertension per 1000 registered patients by quarter (Oct 01 to Sept 04) Apr-Jun02 Jul-Sept02 Oct-Dec02 Jan-Mar03 Data source: QRESEARCH database version 5 109.3 110.7 112.0 113.0 114.0 115.0 115.4 Apr-Jun03 Jul-Sept03 Oct-Dec03 Jan-Mar04 Apr-Jun04 Jul-Sept04 Page 11 of 31

5.6 Hypertension Indicator 2: % with smoking status recorded Indicator BP2: The percentage of patients with hypertension whose notes record smoking status at least once since diagnosis.. Exclusions: General exclusions apply. No indicator specific exclusions. The next charts show the practice variation of recording of smoking status since diagnosis of hypertension in the last quarter of 2004 (July to September 2004). The corresponding tabular data are in the appendix (Table 4, page 26) Overall recording rates are reasonably high (median 91%) with a reasonable spread between practices (inter quartile range IQR 85% to 94%). Inter-practice variation in % of hypertensives with smoking status (Hypertension indicator 2, July-Sept 04) Number of practices 0 10 20 30 40 50 60 70 60 65 70 75 80 85 90 95 100 % of hypertensives with smoking status recorded since diagnosis Data source: QRESEARCH database, version 5 Page 12 of 31

5.7 Hypertension Indicator 2: Quarterly Trends The next chart shows quarterly trends in the percentage of hypertensive patients with smoking status recorded. There has been a substantial rise over the 12 quarters from 66% (October to December 2001) to 91% (July to September 2004). The corresponding tabular data are in the appendix (Table 4, page 26) This search has been done using the Read codes defined in the new GMS contract. It is important to note, however, that many EMIS practices were using EMIS specific codes for smoking prior to April 2004 and this rise is highly likely to reflect a change in the codes used rather than a substantial increase in recording rates. The prevalence of smokers changed very little over the 12 quarters with 13% of hypertensive patients recorded as smokers in quarter 1 and also in quarter 12 (see appendix). % of eligible hypertensives with smoking status 00 20 40 60 80 100 Oct-Dec 01 Trends in median practice % of hypertensives with smoking status Hypertension indicator 2 by quarter (Oct 01 to Sept 04) 66.1 67.9 68.0 69.1 70.5 72.2 73.8 Jan-Mar02 Apr-Jun02 Jul-Sept02 Oct-Dec02 Jan-Mar03 Data source: QRESEARCH database version 5 Apr-Jun03 76.5 Jul-Sept03 79.9 Oct-Dec03 84.9 Jan-Mar04 87.8 Apr-Jun04 90.7 Jul-Sept04 Page 13 of 31

5.8 Hypertension Indicator 3: % of smokers receiving smoking cessation advice Indicator BP3: The percentage of patients with hypertension who smoke, whose notes contain a record that smoking cessation advice or referral to a specialist service, if available, has been offered at least once. Exclusions: General exclusions apply. No indicator specific exclusions. The next chart shows the inter-practice variation in smoking history recorded since diagnosis of hypertension in quarter 12 (July to September 2004). Overall rates were high: the median rate was 91% with a relatively wide (inter-quartile range 81% to 96%). The corresponding tabular data can be found in the appendix (Table 6, page 23) Inter-practice variation in % of smokers given cessation advice (Hypertension indicator 3, July-Sept 04) Number of practices 0 20 40 60 80 100 120 140 0 10 20 30 40 50 60 70 80 90 100 % of hypertensive smokers given cessation advice Data source: QRESEARCH database, version 5 Page 14 of 31

5.9 Hypertension indicator 3: Quarterly Trends The next chart shows how trends in the percentage of smokers given smoking cessation advice has changed over the 12 quarters. The corresponding tabular data can be found in the appendix (Table 6, page 23) In quarter 1 (October December 2001) the median practice percentage was 46% (inter quartile range 17% to 72%). By quarter 12, this had more than doubled to 91% and the inter-practice variation had lessened (81% to 96%). % of hypertensive smokers given cessation advice 00 20 40 60 80 100 46.1 Oct-Dec 01 Trends in median practice % of smokers given cessation advice Hypertension indicator 3 by quarter(oct 01 to Sept 04) Jan-Mar02 48.5 50.0 Apr-Jun02 52.5 Jul-Sept02 56.7 Oct-Dec02 60.5 Jan-Mar03 Data source: QRESEARCH database version 5 63.6 Apr-Jun03 68.0 Jul-Sept03 75.6 Oct-Dec03 84.0 Jan-Mar04 87.7 Apr-Jun04 90.8 Jul-Sept04 Page 15 of 31

5.10 Hypertension Indicator 4: % with a blood pressure recorded Indicator BP4: The percentage of patients with hypertension who have a record of blood pressure in the last 9 months Specific exclusions: Patients with a Read code for exception from blood pressure recording. Rates for blood pressure recording are high as expected with a median practice percentage of 88% in the 12 th quarter and a relatively narrow inter-practice variation (84% to 92%). It is notable, however, that the tail to the left of the graph shows a few practices with low rates even for this indicator. The corresponding tabular data can be found in the appendix (Table 8, page 30) Inter-practice variation in % of hypertensives with BP check in last 9 months (Hypertension indicator 4, July-Sept 04) Number of practices 0 20 40 60 80 100 120 20 30 40 50 60 70 80 90 100 % of hypertensives with BP check in last 9 months Data source: QRESEARCH database, version 5 Page 16 of 31

5.11 Hypertension Indicator 4: Exclusions There were 4 patients with hypertension who had a blood pressure exception reporting code recorded in the 12 th quarter and none before this. 5.12 Hypertension indicator 4: Quarterly Trends The next chart shows trends in the percentage of patients with hypertension with a blood pressure check over the 12 quarters. In quarter 1 (October December 2001) the median practice percentage was 80% (inter quartile range 70% to 87%). By quarter 12, this had increased to 88% and the inter-practice variation had lessened (84% to 92%). % of hypertensives 00 20 with 40 BP check 60 in last 80 9 months Trends in median practice % of hypertensives with BP check in last 9 months Hypertension indicator 4 by quarter(oct 01 to Sept 04) Oct-Dec 01 80.1 80.7 81.7 82.2 82.7 83.4 83.5 84.3 84.7 85.9 86.9 88.2 Jan-Mar02 Apr-Jun02 Jul-Sept02 Oct-Dec02 Jan-Mar03 Data source: QRESEARCH database version 5 Apr-Jun03 Jul-Sept03 Oct-Dec03 Jan-Mar04 Apr-Jun04 Jul-Sept04 Page 17 of 31

5.13 Hypertension Indicator 5: % with a BP of 150 and 90 mm Hg or less Indicator BP5: The percentage of patients with hypertension in whom the last blood pressure is 150/90 or less Specific exclusions: patients with a Read code indicating maximal anti-hypertensive treatment The next chart shows the inter-practice variation in the percentage of hypertensive patients with a blood pressure of 150/90 mm hg or less. The corresponding tabular data can be found in the appendix(see Table 9, page 31). The median practice rate for the percentage of hypertensives with a blood pressure of 150/90 mm Hg or less in quarter 12 (July to October 2004) as 67% (inter-quartile range 60% to 72%). Inter-practice variation in % of hypertensives with BP <=150/90 mmhg (Hypertension indicator 5, July-Sept 04) Number of practices 0 10 20 30 40 50 60 70 80 90 100 10 20 30 40 50 60 70 80 90 100 % of hypertensives with BP of 150/90 mmhg or less Data source: QRESEARCH database, version 5 Page 18 of 31

5.14 Hypertension Indicator 5: Exclusions Although the overall rates are too low to show graphically, the number of patients with a code for maximum antihypertensive therapy rose from 122 in quarter 9 (October to December 2003) to 2,289 in quarter 12 (July to October 2004). The corresponding tabular data can be found in the appendix (Table 7, page 29) The median practice percentage was 0.25 (inter-quartile range 0 to 0.7%). The interpractice variation for the 12 th quarter is shown in the chart below. It is important to realise that this is a diagnostic code entered by the GP the measurement is not based on actual prescribed treatment and many more patients may be on triple (or quadruple) antihypertensive therapy since resistant hypertension and intolerance to antihypertensive drugs is relatively common. Inter-practice variation in % of hypertensives with a maximal hypertensive therapy code (July-Sept 04) Number of practices 0 50 100 150 200 250 300 350 0 2 4 6 8 10 12 14 % of hypertensives with a maximal hypertensive therapy code Data source: QRESEARCH database, version 5 Page 19 of 31

5.15 Hypertension Indicator 5: Quarterly Trends The next chart shows how trends in the percentage of hypertensive patients with a blood pressure value of 150/90 mm HG or less has changed over the 12 quarters. The corresponding tabular data can be found in the appendix (Table 9, page 31). In quarter 1 (October December 2001) the median practice percentage was 47% (inter quartile range 40% to 55%). By quarter 12, this had increased to 66% (inter-practice variation 60% to 72%). % of hypertensives with BP of 150/90 or less 00 20 40 60 80 Oct-Dec 01 Trends median practice % of hypertensives with BP of 150/90 or less Hypertension indicator 5 by quarter(oct 01 to Sept 04) 46.5 47.3 Jan-Mar02 49.4 Apr-Jun02 Jul-Sept02 52.0 51.2 51.4 Oct-Dec02 Jan-Mar03 Data source: QRESEARCH database version 5 54.0 Apr-Jun03 Jul-Sept03 56.2 56.5 Oct-Dec03 58.7 Jan-Mar04 62.6 Apr-Jun04 66.7 Jul-Sept04 Page 20 of 31

6 DISCUSSION The prevalence of hypertension in our study is higher than that in other primary care studies 1 and has increase significantly over the 12 quarters studied in the report. This may be because the population prevalence of hypertension is increasing; the definition of hypertension has changed with lower threshold values for diagnosis. Alternatively it may reflect improvements in case finding or data quality. We found a significant variation between practices in the recording of almost all of the indicators. Our study design does not allow us to determine whether this is due to variation in the quality of care or differences in the completeness of data entry though the electronic record tends to be more complete than the paper record 2. However, there was a marked reduction in the variation between practices over the 12 quarters. In terms of the first two objectives set (to report on performance against indicators and inter-practice variation), all practices could meet the requirement for a disease register for hypertension (Indicator 1). The prevalence of hypertension has risen from the first quarter (October - December 2001) when it was 97 per 1,000 to 115 per 1,000 registered patients by the last quarter examined (July September 2004). This rate is higher than other studies, but the slow steady rise is unlikely to be due to data artefact, and is more likely to be due to increased case detection and improved life expectancy. Certainly there is no sign of a ngms provoked surge or drop. There is substantial inter-practice variation in prevalence of hypertension with a normal distribution. For many practices this is almost certainly an expression of the variation in their practice population but the outliers at either end may be under or over diagnosing or recording. The number of patients with hypertension and smoking status recorded (Indicator 2) varies markedly between practices with a long tail at the lower end suggesting that movement towards the mean is possible for a number of practices. The trend is upwards with over 90% having smoking status recorded by the last quarter of 2004. There is no evidence of a ngms surge, but it would be expected that the trend will continue up, with low outliers in particular catching up. The recording of smoking cessation advice (Indicator 3) is over 50% except in a very small number of practices. Overall this indicator has exceeded 90% in the last quarter and again the ngms pressures are likely to continue this trend. There is much less inter-practice variation in the proportion of people with hypertension who have a recorded blood pressure reading in the previous 9 months (Indicator 4). By the final quarter in 2004 the steady trend had yielded a rise from 80% to 88% overall. Page 21 of 31

In terms of hypertensive control (BP of 150/90 or less Indicator 5) there has been a gratifying rise from 46% to 67% over the 3 years, with a steeper rise in recent quarters. The inter-practice variation is much as might be expected for such an indicator. We were also asked to look at use of exception codes. In recent quarters there has been some use of the hypertension resolved codes but it is still minimal and probably reflects misdiagnoses, coding errors and genuinely resolved hypertension. The use is too small to impact on the analyses for the QoF, but usage is increasing in recent quarters and might become a significant issue in time. A similar story applies to Hypertension exception codes which are used 10 times more frequently than hypertension resolved codes, and with use increasing in recent quarters. Maximum therapy exclusion codes were used at a similar level to the hypertension exception codes. Both these latter might become sufficiently used, if current trends continue, to impact on QoF analyses. Blood pressure recording exception codes were only present in 4 patients. These data, reported at the very start of the new GMS contract, will be of interest to practices as they plan their delivery strategies and to health service planners responsible for monitoring and remuneration. The large variation between practices in levels of outcomes achieved was expected although the overall values achieved were lower than expected for several indicators (in particular indicator 5) indicating the substantial amount of work needed to provide optimum care for all patients. 7 FUTURE WORK Future reports will present similar analyses of the other conditions covered by the new General Medical Services Contract. 8 REFERENCES 1. Newnham A, Ryan R, Khunti K, Majeed A. Prevalence of diagnosed diabetes mellitus in general practice in England and Wales. Health Statistics Quarterly 2002;14:5-13. 2. Hippisley-Cox J, Pringle M, Cater R, Wynn A, Hammersley V, Coupland C, et al. Electronic record in primary care - regression or progression? Cross-sectional survey. BMJ 2003;326:1439-1443. Page 22 of 31

9 APPENDIX Table 1: Trends in median practice prevalence rate of hypertension per 1000 registered patients Start of quarter Total patients with hypertension Registered patients Practice median prevalence rate per 1000 registered patients 25th 75th 01-Oct-01 321,649 3,371,828 97.0 77.1 116.6 01-Jan-02 330,895 3,372,749 99.1 79.3 118.8 01-Apr-02 338,936 3,376,356 101.4 82.2 120.2 01-Jul-02 345,282 3,396,358 102.7 83.8 122.6 01-Oct-02 351,644 3,391,864 105.8 85.7 125.3 01-Jan-03 359,904 3,393,214 109.3 88.6 127.9 01-Apr-03 366,150 3,396,352 110.7 89.6 129.3 01-Jul-03 371,440 3,411,704 112.0 90.5 132.4 01-Oct-03 376,822 3,409,348 113.0 91.8 134.2 01-Jan-04 382,115 3,406,060 114.0 93.5 136.7 01-Apr-04 386,045 3,410,710 115.0 94.5 137.8 01-Jul-04 388,442 3,420,653 115.4 94.9 138.4 Page 23 of 31

Table 2: Trends in practice median percentage with hypertension resolved code Start of quarter Total patients with hypertension resolved code Total patients with hypertension Practice median percentage with hypertension resolved code 25th 75th 01-Oct-01 36 321,649 0.0 0.0 0.0 01-Jan-02 34 330,895 0.0 0.0 0.0 01-Apr-02 34 338,936 0.0 0.0 0.0 01-Jul-02 32 345,282 0.0 0.0 0.0 01-Oct-02 33 351,644 0.0 0.0 0.0 01-Jan-03 39 359,904 0.0 0.0 0.0 01-Apr-03 36 366,150 0.0 0.0 0.0 01-Jul-03 40 371,440 0.0 0.0 0.0 01-Oct-03 38 376,822 0.0 0.0 0.0 01-Jan-04 112 382,115 0.0 0.0 0.1 01-Apr-04 136 386,045 0.0 0.0 0.3 01-Jul-04 219 388,442 0.1 0.0 0.6 Page 24 of 31

Table 3: Trends in median practice percentage with hypertension exception code Start of quarter Total patients with hypertension exception code Total patients with hypertension Median practice percentage with hypertension exception code 25th 75th 01-Oct-01 2 321,649 0.0 0.0 0.0 01-Jan-02 2 330,895 0.0 0.0 0.0 01-Apr-02 2 338,936 0.0 0.0 0.0 01-Jul-02 2 345,282 0.0 0.0 0.0 01-Oct-02 2 351,644 0.0 0.0 0.0 01-Jan-03 3 359,904 0.0 0.0 0.0 01-Apr-03 6 366,150 0.0 0.0 0.0 01-Jul-03 11 371,440 0.0 0.0 0.0 01-Oct-03 106 376,822 0.0 0.0 0.0 01-Jan-04 521 382,115 0.0 0.0 0.0 01-Apr-04 1,055 386,045 0.0 0.0 0.0 01-Jul-04 1,900 388,442 0.0 0.0 0.0 Page 25 of 31

Table 4 Practice median % of hypertension patients with smoking history recorded since diagnosis Start of quarter Total hypertension patients with smoking history since diagnosis Total hypertension patients eligible for smoking history Practice median % of hypertension patients with smoking history recorded since diagnosis 25th 75th 01-Oct-01 205,701 312,609 66.1 54.7 76.9 01-Jan-02 214,121 320,316 67.9 55.1 78.3 01-Apr-02 223,012 329,766 68.0 56.5 79.4 01-Jul-02 231,203 337,281 69.1 57.3 80.3 01-Oct-02 238,866 343,145 70.5 58.5 81.2 01-Jan-03 249,170 350,317 72.2 60.3 82.5 01-Apr-03 259,855 358,295 73.8 62.3 83.7 01-Jul-03 271,609 364,561 76.5 65.2 84.8 01-Oct-03 287,828 369,516 79.9 69.7 87.4 01-Jan-04 311,212 375,611 84.9 76.8 90.6 01-Apr-04 326,690 380,332 87.8 81.2 92.3 01-Jul-04 340,728 382,894 90.7 85.3 94.4 Page 26 of 31

Table 5 Practice median % of hypertension patients who smoke Start of quarter current smokers Total hypertension patients Practice median % of hypertension patients who smoke 25th 75th 01-Oct-01 49,627 321,649 13.5 10.8 17.7 01-Jan-02 50,585 330,895 13.6 10.8 17.4 01-Apr-02 51,584 338,936 13.7 10.8 17.3 01-Jul-02 52,376 345,282 13.8 11.0 17.4 01-Oct-02 53,131 351,644 13.8 11.1 17.4 01-Jan-03 53,875 359,904 13.8 11.0 17.3 01-Apr-03 54,401 366,150 13.7 10.9 17.3 01-Jul-03 54,917 371,440 13.7 11.1 17.4 01-Oct-03 55,257 376,822 13.7 11.2 17.3 01-Jan-04 54,819 382,115 13.6 10.9 17.3 01-Apr-04 54,519 386,045 13.4 10.8 17.1 01-Jul-04 54,467 388,442 13.4 11.0 17.0 Page 27 of 31

Table 6 Practice median % of hypertension patients who smoke who have had smoking advice given ever Start of quarter Total hypertension who smoke given advice ever Total hypertension patients who smoke Practice median % of hypertension patients who smoke who have had smoking advice given ever 25th 75th 01-Oct-01 21,467 47,942 46.1 16.8 71.7 01-Jan-02 22,781 48,739 48.5 19.4 73.3 01-Apr-02 24,271 49,843 50.0 22.3 75.5 01-Jul-02 25,561 50,777 52.5 25.9 76.4 01-Oct-02 26,937 51,553 56.7 28.9 77.5 01-Jan-03 28,720 52,122 60.5 34.3 79.0 01-Apr-03 30,784 52,937 63.6 41.8 81.2 01-Jul-03 33,282 53,525 68.0 47.5 84.3 01-Oct-03 36,854 54,027 75.6 55.6 88.0 01-Jan-04 40,856 53,730 84.0 67.1 92.4 01-Apr-04 43,543 53,586 87.7 74.9 94.1 01-Jul-04 45,905 53,502 90.8 81.3 95.9 Page 28 of 31

Table 7: Practice median percentage of patients with hypertension with a code for maximal antihypertensive therapy code Start of quarter Total patients with maximal therapy code Total patients with hypertension Practice median percentage with maximal therapy code 25th 75th 01-Oct-01 2 321,649 0.0 0.0 0.0 01-Jan-02 3 330,895 0.0 0.0 0.0 01-Apr-02 5 338,936 0.0 0.0 0.0 01-Jul-02 5 345,282 0.0 0.0 0.0 01-Oct-02 5 351,644 0.0 0.0 0.0 01-Jan-03 5 359,904 0.0 0.0 0.0 01-Apr-03 7 366,150 0.0 0.0 0.0 01-Jul-03 27 371,440 0.0 0.0 0.0 01-Oct-03 122 376,822 0.0 0.0 0.0 01-Jan-04 768 382,115 0.0 0.0 0.2 01-Apr-04 1,490 386,045 0.1 0.0 0.5 01-Jul-04 2,289 388,442 0.2 0.0 0.7 Page 29 of 31

Table 8 Practice median % of hypertension patients who have had BP check in the last 9 months Start of quarter Total hypertension patients with blood pressure check in last 9 months Total hypertension patients eligible for blood pressure check Practice median % of hypertension patients who have had BP check in the last 9 months 25th 75th 01-Oct-01 250,040 320,607 80.1 69.9 86.8 01-Jan-02 259,846 329,246 80.7 71.8 86.8 01-Apr-02 270,440 337,940 81.7 73.9 87.5 01-Jul-02 278,662 344,274 82.2 74.4 87.2 01-Oct-02 285,916 350,819 82.7 75.1 87.6 01-Jan-03 294,547 358,771 83.4 76.9 87.9 01-Apr-03 301,058 365,413 83.5 77.5 87.8 01-Jul-03 308,659 370,634 84.3 78.8 88.7 01-Oct-03 315,598 376,245 84.7 79.0 89.1 01-Jan-04 324,589 381,606 85.9 81.0 90.0 01-Apr-04 331,054 385,615 86.9 82.6 90.4 01-Jul-04 337,332 388,025 88.2 84.3 91.6 Page 30 of 31

Table 9 Practice median % of hypertension patients who have BP <=159/90 mmhg Start of quarter Total hypertension patients with BP 150/90 or less Total eligible for BP value checks Practice median % of hypertension patients who have BP <=159/90 mmhg 25th 75th 01-Oct-01 143,356 302,893 46.5 39.6 55.3 01-Jan-02 147,750 310,476 47.3 39.3 55.0 01-Apr-02 158,753 318,246 49.4 41.5 56.6 01-Jul-02 171,392 326,173 52.0 44.3 59.4 01-Oct-02 172,978 332,918 51.2 44.1 59.4 01-Jan-03 176,827 340,324 51.4 44.5 58.9 01-Apr-03 188,621 347,891 54.0 47.3 60.5 01-Jul-03 201,464 354,384 56.2 49.9 63.8 01-Oct-03 204,872 360,157 56.5 50.0 64.2 01-Jan-04 213,921 365,190 58.7 52.4 65.9 01-Apr-04 230,269 370,939 62.6 56.1 69.4 01-Jul-04 244,794 374,210 66.7 60.1 71.7 Page 31 of 31